<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03339427</url>
  </required_header>
  <id_info>
    <org_study_id>VitD301</org_study_id>
    <nct_id>NCT03339427</nct_id>
  </id_info>
  <brief_title>Intervention Study of Vitamin D Supplementation to Prevent Cardiovascular Disease</brief_title>
  <official_title>Study of Vitamin D Deficiency on Cardiovascular Disease and the Effect of Vitamin D Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 9 months, randomized, single center, open-label, parallel-group study to compare&#xD;
      the efficacy and safety parameters of vitamin D supplementation in vitamin D deficiency&#xD;
      subjects in China.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 9 months, randomized, single center, open-label, parallel-group study to compare&#xD;
      the efficacy and safety parameters of vitamin D supplementation in vitamin D deficiency&#xD;
      subjects in China.&#xD;
&#xD;
      Eligibility for participation will be determined by medical history, physical examination,&#xD;
      and laboratory results obtained during a screening visit. About 300 subjects with vitamin D&#xD;
      insufficiency or deficiency will be included in this study. All subjects will be given&#xD;
      informed consent before starting any examination and test. The following data of all subject&#xD;
      will be collected: liver and kidney function, HbA1c, fasting blood glucose, fasting lipid&#xD;
      profile, serum calcium, serum phosphate, parathyroid hormone, 25-hydroxy vitamin D(25OHD),&#xD;
      serum procollagen type I N propeptide, serum C-terminal telopeptide of type I collagen, s-CTX&#xD;
      and muscle power and balance.&#xD;
&#xD;
      After baseline data are collected, eligible subjects will be randomized into each group at a&#xD;
      1:1 ratio (150 for control group and 150 for vitamin D supplementation group, less than 20%&#xD;
      drop-off rate is acceptable for this study). The initial vitamin D doses will be based on&#xD;
      25OHD levels at basis, and this dosage may be changed according be the level of 25OHD until&#xD;
      the end of this study.&#xD;
&#xD;
      All subjects in the control group will be followed every half year. All subjects in the&#xD;
      vitamin D group will be followed by visiting clinic, and will be titrated their doses. Dose&#xD;
      adjustment should be aimed at achieving the following 25OHD targets: 30ng/ml. If above 25OHD&#xD;
      target has not been achieved, vitamin D dose should be adjusted. Clinic visit will be&#xD;
      conducted 3 months later to collect information, such as serum calcium, 25OHD and adverse&#xD;
      events.&#xD;
&#xD;
      Complicated examinations will be repeated again after 9 months treatments for both groups,&#xD;
      including physical examination, liver and kidney function, HbA1c, fasting blood glucose,&#xD;
      fasting lipid profile, serum calcium, serum phosphate, parathyroid hormone, 25-hydroxy&#xD;
      vitamin D(25OHD), serum procollagen type I N propeptide, serum C-terminal telopeptide of type&#xD;
      I collagen, s-CTX and muscle power and balance. Data will be collected and analyzed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The efficacy on serum 25(OH)VitD level</measure>
    <time_frame>9 months</time_frame>
    <description>The change of serum 25(OH)VitD level after vitamin D supplementation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The efficacy on metabolic syndrome</measure>
    <time_frame>9 months</time_frame>
    <description>The change of metabolic syndrome after vitamin D supplementation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The efficacy on bone biomarkers</measure>
    <time_frame>9 months</time_frame>
    <description>The change of bone biomarkers after vitamin D supplementation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The efficacy on blood pressure</measure>
    <time_frame>9 months</time_frame>
    <description>The change of blood pressure after vitamin D supplementation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The efficacy on blood lipid</measure>
    <time_frame>9 months</time_frame>
    <description>The change of blood lipid after vitamin D supplementation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The efficacy on blood glucose</measure>
    <time_frame>9 months</time_frame>
    <description>The change of blood glucose after vitamin D supplementation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>vitamin D,capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A total of 150 subjects were recruited in the vitamin D supplementation group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A total of 150 subjects were recruited in the control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>vitamin D</intervention_name>
    <description>different doses of vitamin D supplementation</description>
    <arm_group_label>vitamin D,capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>control group</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Informed consent obtained before any trial-related activities. (Trial- related&#xD;
             activities are any procedure that would not have been performed during normal&#xD;
             management of the subject.)&#xD;
&#xD;
          2. 25OHD&lt;30ng/ml&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Severe systemic disease (including severe heart, liver, kidney and lung diseases,&#xD;
             severe infection, mental disorder and connective tissue disease)&#xD;
&#xD;
          2. Primary hyperparathyroidism, other bone disease, malabsorption and other chronic&#xD;
             gastrointestinal disease.&#xD;
&#xD;
          3. Pregnant, breast-feeding or the intention of becoming pregnant or not using adequate&#xD;
             contraceptive measures.&#xD;
&#xD;
          4. Use of systemic or inhaled glucocorticoids or other medication known to interfere with&#xD;
             bone metabolism.&#xD;
&#xD;
          5. Use of vitamin D related agents in recent 3 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chunlin Li, M.D&amp;Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>PLA General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <study_first_submitted>June 19, 2014</study_first_submitted>
  <study_first_submitted_qc>November 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>November 8, 2017</last_update_submitted>
  <last_update_submitted_qc>November 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Chunlin Li</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>vitamin D</keyword>
  <keyword>cardiovascular</keyword>
  <keyword>muscle power</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

